Operating Lease, Right-of-Use Asset of CVS HEALTH Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CVS HEALTH Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • CVS HEALTH Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $15,271,000,000, a 5.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CVS HEALTH Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,271,000,000 -$960,000,000 -5.9% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $15,512,000,000 -$1,389,000,000 -8.2% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $15,704,000,000 -$1,341,000,000 -7.9% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $15,944,000,000 -$1,308,000,000 -7.6% 31 Dec 2024 10-Q 29 Oct 2025 2025 Q3
Q3 2024 $16,231,000,000 -$1,333,000,000 -7.6% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $16,901,000,000 -$802,000,000 -4.5% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $17,045,000,000 -$615,000,000 -3.5% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $17,252,000,000 -$620,000,000 -3.5% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $17,564,000,000 -$706,000,000 -3.9% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $17,703,000,000 -$859,000,000 -4.6% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $17,660,000,000 -$1,141,000,000 -6.1% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $17,872,000,000 -$1,250,000,000 -6.5% 31 Dec 2022 10-K 07 Feb 2024 2023 FY
Q3 2022 $18,270,000,000 -$2,192,000,000 -11% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $18,562,000,000 -$1,914,000,000 -9.3% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $18,801,000,000 -$1,741,000,000 -8.5% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $19,122,000,000 -$1,607,000,000 -7.8% 31 Dec 2021 8-K 25 May 2023
Q3 2021 $20,462,000,000 -$22,000,000 -0.11% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $20,476,000,000 -$95,000,000 -0.46% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $20,542,000,000 -$130,000,000 -0.63% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $20,729,000,000 -$131,000,000 -0.63% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 $20,484,000,000 -$273,000,000 -1.3% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $20,571,000,000 -$294,000,000 -1.4% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $20,672,000,000 -$320,000,000 -1.5% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $20,860,000,000 +$20,860,000,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $20,757,000,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $20,865,000,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $20,992,000,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.